HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pregnant Women In Developing Countries Should Consider MVMs – Study

This article was originally published in The Tan Sheet

Executive Summary

Multivitamins should be "considered for all pregnant women in developing countries," according to authors of a study in the April 5 New England Journal of Medicine

You may also be interested in...



Multivitamins improve birth outcomes in HIV-positive pregnant women -- Harvard study.

MULTIVITAMINS REDUCE FETAL DEATH RISK AMONG HIV-INFECTED MOTHERS in a study of 1,075 Tanzanian women, Wafaie Fawzi, MD, Harvard School of Public Health, et al., report in the May 16 issue of the Lancet. Multivitamins also led to a reduction in low birth weight, a reduction in severe preterm births and an improvement in the immune status of the mothers, the researchers say.

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS138194

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel